Y-Biologics recorded two insider trading transactions during the past ninety days, both involving purchases by Representative Directors. Park Young woo and Park Bum chan acquired shares totaling 27.6 million KRW on October 14, 2026. These acquisitions occurred amid a period where the stock price declined by 30.7 percent.